Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRMD
CTMX
Add up to 3 more stocks
CRMD
CorMedix Inc.
-1.25%
$7.17-0.09Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$562.41M
52W Range
$6.13 - $13.02
CTMX
CytomX Therapeutics, Inc.
-1.36%
$2.54-0.04Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$554.05M
52W Range
$2.48 - $8.21
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 3.37 | N/A |
| Forward P/E | 14.48 | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 1.22 | 1.83 |
| P/S Ratio | 1.22 | 30.27 |
| P/FCF Ratio | 2.25 | N/A |
| EV/EBITDA | 1.79 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 82.8% | 98.6% |
| Operating Margin | 47.0% | -29.4% |
| Net Margin | 40.5% | -435.2% |
| ROE | 40.6% | -26.4% |
| ROA | 20.7% | -20.9% |
| ROIC | 27.9% | -25.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.56 | 9.36 |
| Quick Ratio | 2.36 | 9.36 |
| Debt/Equity | 0.31 | 0.02 |
| Interest Coverage | 53.97 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.